Find information on thousands of medical conditions and prescription drugs.

Hereditary amyloidosis

Amyloid describes various types of protein aggregations that share specific traits when examined microscopically. The name amyloid comes from the early mistaken identification of the substance as starch (amylum in Latin), based on crude iodine-staining techniques. For a period the scientific community debated whether or not amyloid deposits were fatty deposits or carbohydrate deposits until it was finally resolved that it was neither, rather a deposition of proteinaceous mass. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Specifically, amyloid deposits are extracellular, thioflavin s positive, and exhibit apple-green birefringence when stained with congo red. Other indicators exist, such as serum amyloid p-component binding. Since these are indirect indicators, biophysicists have redefined amyloid using a canonical set of biophysical characteristics (see below), and this seems to cause a low level of conflict between histologists and biophysicists.

The phenotypes of genetically transmitted amyloid diseases are often inherited in an autosomal dominant fashion. Sometimes, the difference between aggressive amyloid diseases and senescent amyloid diseases is due to a mutation which makes the protein more prone to aggregation. Most commonly seen are point mutations which affect the cohesiveness of the protein and promote misfolding; other mutations cause aggregation-prone pieces of the protein to be cleaved off from the rest of the protein.

Diseases featuring amyloid

It should be noted that in almost all of the organ-specific pathologies, there is significant debate as to whether the amyloid plaques are the causal agent of the disease or if they are instead a symptom downstream of a common ideopathic agent. The associated proteins are indicated in parentheses.

  • Systemic amyloidosis
    • Primary amyloidosis
      • Mutations in lysozyme, transthyretin, apolipoprotein B, fibrinogen
    • Secondary amyloidosis
      • AA amyloidosis (amyloid A protein, an acute phase protein due to chronic inflammation)
      • AL amyloidosis (immunoglobulin light chains)
      • Gelsolin amyloidosis (plasma gelsolin fragments).
    • Familial or Hereditary amyloidosis
      • Most commonly caused by mutations in the transthyretin protein, but in rare occurrences can also be caused by apolipoprotein A1, gelsolin, fibrinogen, and lysozyme mutations.
      • Primarily caused by genetics, believed to be autosomal dominant, high probability of passage to offspring
      • Appalachian type amyloidosis is perhaps the most well known type
  • Organ-specific amyloidosis
    • Diabetes mellitus type 2 (amylin, also known as IAPP)
    • Neurology
      • Alzheimer's disease (Aβ 39-42)
      • Parkinson's disease (alpha-synuclein) -- biophysical definition
      • Huntington's disease (huntingtin) -- biophysical definition
      • Spongiform encephalopathies
        • Creutzfeldt-Jakob disease (PrP in cerebrum)
        • Kuru (diffuse PrP deposits in brain)
        • Fatal Familial Insomnia (PrP in thalamus)
        • Bovine spongiform encephalopathy (PrP in cerebrum)
      • Congophilic angiopathy (Amyloid beta)
      • congestive heart failure; some instances (PrP in heart)
    • Inclusion body myositis
  • Iatrogenic conditions
    • insulin amyloidosis (injection-administered insulin)

Read more at Wikipedia.org


[List your site here Free!]


Pulmonary amyloidosis mimicking metastatic breast cancer in a patient with connective tissue disease
From CHEST, 10/1/05 by Maria Carrillo

INTRODUCTION: Unlike systemic amyloidosis, when amyloidosis is localized to the lungs, this uncommon condition usually involves the lungs in one of two ways. In can be confined to the tracheobronchial tree as single or multiple lesions, or involve the lung parenchyma as one or more nodules. It only rarely causes diffuse infiltration of the lungs. Its presence can easily be mistaken for other more serious etiologies as this case illustrates.

CASE PRESENTATION: We present a 54 year old Caucasian female diagnosed with infiltrative ductal carcinoma of the breast in 1997. She had a lumpectomy with lymph node dissection which revealed two lymph nodes positive for cancer. She received chemotherapy and hormonal therapy. Radiation therapy was not given because of an underlying diagnosis of SLE. She was diagnosed with SLE and Sjogren's syndrome in 1990 at which time she had renal involvement and received cyclophosphamide for six months followed by azathioprine. More recently she has been on methotrexate and hydroxychloroquine. She was referred to us after a chest radiograph and CT of the chest showed right middle lobe airspace disease and multiple nodules throughout both lung fields that were highly suspicious for metastatic breast carcinoma. This was evaluated previously at another hospital where she had a bronchoscopy that revealed atypical cells. She subsequently underwent open lung biopsy, which reported patchy lymphoid aggregates and chronic inflammation. We obtained these biopsies taken from the right middle lobe and lower lobe. The biopsies demonstrated a waxy nodular material. Alkaline Congo Red stain of this material was positive for apple-green birefringence under polarized light that was consistent with pulmonary nodular amyloidosis. It also showed evidence of lymphoid hyperplasia and follicular bronchiolitis consistent with her connective tissue disease. There were emphysematous changes compatible with her past 30-40 pack year smoking history and moderate airways obstruction noted on pulmonary function testing.

DISCUSSIONS: Amyloidosis is usually systemic in nature and when it involves the lungs it is diffuse, infiltrative, and asymptomatic. It is can be idiopathic in nature, hereditary, or associated with underlying inflammatory or hematologic disorders such as myeloma. Pulmonary nodular amyloidosis, though rare, is limited to the lungs. An extensive evaluation looking for other predisposing causes for amyloidosis was negative, as was the evaluation looking for other organ involvement, including core biopsy of the abdominal fat pad. Pulmonary nodular amyloidosis is a rare condition, and even more uncommonly it has been associated with Sjogren's syndrome. The few reports describe it as cystic changes, lymphoplasmocytic infiltrates, or irregular noncavitary nodules. In this particular case, the appearance was compatible with metastatic disease as well as a possible drug reaction.

CONCLUSION: Pulmonary nodular amyloidosis can mimic other more serious entities such as metastatic breast cancer as in this case. It can be missed on histopathology unless it is considered in the differential and special stains are performed. The nodular distribution suggests it is not secondary to the often more life threatening causes of systemic amyloidosis which include malignant disorders. This patient's Sjogren's syndrome was the most likely condition that predisposed her to develop this rare complication of this disease.

DISCLOSURE: Maria Carrillo, None.

Maria Carrillo MD * Mihela Sescioreanu MD Zachary Q. Morris MD Henry Ford Hospital, Detroit, MI

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Hereditary amyloidosis
Home Contact Resources Exchange Links ebay